Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Overdose Deaths Predicted to Drop 24% Year-Over-Year in U.S.: CDC New data shows that the number of deaths from drug overdoses may have declined significantly between 2023 and 2024, averaging 70 lives saved per day. March 13, 2025 Darian Hauf Add Your Comments Federal regulators have determined that U.S. drug overdose deaths for the most recently analyzed 12-month period could be at their lowest point since June 2020. Drug overdoses are the leading cause of death for Americans between the ages of 18 and 44, primarily due to opioids such as heroin and fentanyl. However, the U.S. Centers for Disease Control and Prevention’s (CDC) National Vital Statistics System released an Overdose Deaths Report late last month, predicting a nearly 24% decline in drug overdose deaths in the United States from October 2023 through September 2024. The provisional data estimates 87,000 deaths for the period, down from 114,000 the previous year, which is a decrease of more than 27,000 deaths, equating to an average of over 70 lives saved each day. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to the CDC data, 45 states showed declines in overdose deaths, with only Alaska, Montana, Nevada, South Dakota and Utah seeing increases. The number of non-fatal overdoses and self-reported youth substance use has also declined. The CDC attributes the decline in deaths to a number of factors, including: Widespread distribution of naloxone, a life-saving medication that can reverse overdoses, Better access to evidence-based treatment for substance use disorders, Shifts in the illegal drug supply, and Investments in prevention and response programs. One important program is the CDC’s Overdose Data to Action (OD2A) program, which provides the U.S. with a fatal and nonfatal overdose data system that state and local public health departments can use to inform which prevention efforts are able to save the most lives. The CDC also funds the Overdose Response Strategy, an innovative collaboration across all states that merges public health and safety data. This program enables law enforcement officials to use data analytics to enhance their understanding of and intercept illegal drug activities more effectively. Federal regulators further indicated that expanded access to treatment, which includes opioid medications, more community-driven interventions and better education, is critical to reducing the number of deaths. U.S. Opioid Crisis President Trump declared opioid overdoses a public health emergency in 2017. Prior to the designation, a report in 2013 found that women may be more likely to become dependent on prescription painkillers than men. The study indicated a 400% increase in overdose deaths among women using prescription pain medication since 1999, compared to a 265% increase among men during the same period. In 2015, drug overdose deaths hit a new high, with prescription painkiller-related deaths increasing by 137% since 2000. A CDC report in 2018 reported that drug overdoses involving opioids accounted for nearly 70% of overdose deaths, with 68% involving opioid-based painkillers. However, another CDC report in 2024 found that drug overdose deaths had fallen by 4% in 2023, marking the first decline in five years. Tags: Drug Abuse, Drug Addiction, Drug Overdose, Fentanyl, Fentanyl Overdose, Heroin, Overdose More Stories Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit March 25, 2025 Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026 March 25, 2025 Cases of Persistent Delirium at Nursing Homes Dropped in Recent Years: Study March 25, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (Posted: today) A hair relaxer lawsuit claims long-term use of chemical straighteners led to the development of uterine and endometrial cancer. MORE ABOUT: HAIR RELAXER LAWSUITSchedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025) Depo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (Posted: yesterday) A federal judge has issued an order outlining the timeline for Depo-Provera lawsuits being prepared for early trials, with discovery set to kickoff this week and the first cases being ready for trial by late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITWomen Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025) Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (Posted: 4 days ago) Pushing back against a motion to dismiss, plaintiffs involved in GLP-1 lawsuits say GLP-1 manufacturers intentionally misled the medical community and patients regarding the safety of the diabetes and weight loss drugs. MORE ABOUT: OZEMPIC LAWSUITGLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)Ozempic Hair Loss Side Effects Doubled for Users, Study Finds (03/07/2025)
Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026 March 25, 2025
Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (Posted: today) A hair relaxer lawsuit claims long-term use of chemical straighteners led to the development of uterine and endometrial cancer. MORE ABOUT: HAIR RELAXER LAWSUITSchedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)
Depo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (Posted: yesterday) A federal judge has issued an order outlining the timeline for Depo-Provera lawsuits being prepared for early trials, with discovery set to kickoff this week and the first cases being ready for trial by late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITWomen Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)
Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (Posted: 4 days ago) Pushing back against a motion to dismiss, plaintiffs involved in GLP-1 lawsuits say GLP-1 manufacturers intentionally misled the medical community and patients regarding the safety of the diabetes and weight loss drugs. MORE ABOUT: OZEMPIC LAWSUITGLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)Ozempic Hair Loss Side Effects Doubled for Users, Study Finds (03/07/2025)